Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster, Vaccination site erythema, Vaccination site induration, Vaccination site swelling, Vaccination site warmth
Clinical narrative: mild case of the shingles on chest; warm to touch area around injection site; red area around injection site the size of the palm of hand; swollen area around injection site the size of the palm of the hand; in the middle of this spot, he also developed a hard spot approximately 3/4 round in diameter; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (mild case of the shingles on chest), VACCINATION SITE WARMTH (warm to touch area around injection site), VACCINATION SITE ERYTHEMA (red area around injection site the size of the palm of hand), VACCINATION SITE SWELLING (swollen area around injection site the size of the palm of the hand) and VACCINATION SITE INDURATION (in the middle of this spot, he also developed a hard spot approximately 3/4 round in diameter) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012A21A and 017B21A) for COVID-19 vaccination.     The patient's past medical history included Stroke (history of strokes and mini strokes) and Cerebrovascular stenosis NOS (History of narrowed blood vessel in brain causing strokes). Concomitant products included TICAGRELOR (BRILINTA) and ACETYLSALICYLIC ACID (ASPIRIN 81) for Anticoagulant therapy, EVOLOCUMAB (REPATHA) for Cholesterol blood increased.   On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Apr-2021, the patient experienced VACCINATION SITE WARMTH (warm to touch area around injection site), VACCINATION SITE ERYTHEMA (red area around injection site the size of the palm of hand), VACCINATION SITE SWELLING (swollen area around injection site the size of the palm of the hand) and VACCINATION SITE INDURATION (in the middle of this spot, he also developed a hard spot approximately 3/4 round in diameter). On 04-Apr-2021, the patient experienced HERPES ZOSTER (mild case of the shingles on chest). The patient was treated with MUPIROCIN (BACTROBAN OINTMENT) on 04-Apr-2021 for Shingles, at a dose of UNK, prn. On 18-Apr-2021, VACCINATION SITE WARMTH (warm to touch area around injection site), VACCINATION SITE ERYTHEMA (red area around injection site the size of the palm of hand), VACCINATION SITE SWELLING (swollen area around injection site the size of the palm of the hand) and VACCINATION SITE INDURATION (in the middle of this spot, he also developed a hard spot approximately 3/4 round in diameter) had resolved. At the time of the report, HERPES ZOSTER (mild case of the shingles on chest) had not resolved.         Company Comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   This case was linked to MOD-2021-209373 (Patient Link).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.